Klausner Richard
Director at LYEL; Director at Juno Therapeutics, Inc.; Sr VP, Chief Medical Officer at ILMN
- Sold, on record
- $11.1M
- Dollars the filings state
- Form 4 sales
- 22
- Latest Aug 15, 2023
- Form 144 notices
- 8
- Proposed sales
- Companies
- 3
- Filed as an executive or holder
Companies
- LYELLyell Immunopharma, Inc.Director
- Juno Therapeutics, Inc.Director
- ILMNILLUMINA, INC.Sr VP, Chief Medical Officer
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- Juno Therapeutics, Inc.256,724 shares
- LYEL69,120 shares
- ILMN2,339 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 144 notice LYELNoticeJul 17, 2023 2023
Filed to sell 3,300 shares ($10k)
Klausner Richard, Officer, Director
No 10b5-1 planFiling
- 2 Form 144 notice LYELNoticeJul 17, 2023 same day
Filed to sell 3,300 shares ($10k)
Klausner Richard, Officer, Director
No 10b5-1 planFiling
- 3 Form 144 notice LYELNoticeJul 17, 2023 same day
Filed to sell 14,500 shares ($42k)
Klausner Richard, Officer, Director
No 10b5-1 planFiling
- 4 Form 144 notice LYELNoticeAug 15, 2023 +29 days
Filed to sell 4,485 shares ($10k)
Klausner Richard, Director
No 10b5-1 planFiling
- 5 Form 144 notice LYELNoticeAug 15, 2023 same day
Filed to sell 44,565 shares ($102k)
Klausner Richard, Director
No 10b5-1 planFiling
- 6 Form 144 notice LYELNoticeAug 15, 2023 same day
Filed to sell 4,485 shares ($10k)
Klausner Richard, Director
No 10b5-1 planFiling
- 7 Form 144 notice LYELNoticeAug 15, 2023 same day
Filed to sell 4,485 shares ($10k)
Klausner Richard, Director
No 10b5-1 planFiling
- 8 Form 4 sale LYELNo planAug 15, 2023 same day
Sold 58,020 shares at $2.28 ($132k)
Klausner Richard, Director
No 10b5-1 planSold 5.9% of holdings ($2.3M position)930,880 shares leftFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (30)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 15, 2023 | Aug 17, 2023 | LYEL | Director | Form 4 sale | 58,020 | $132k | 5.9% | No plan | SEC |
| Aug 15, 2023 | Aug 15, 2023 | LYEL | Director | Form 144 notice | 4,485 | $10k | Notice | SEC | |
| Aug 15, 2023 | Aug 15, 2023 | LYEL | Director | Form 144 notice | 4,485 | $10k | Notice | SEC | |
| Aug 15, 2023 | Aug 15, 2023 | LYEL | Director | Form 144 notice | 44,565 | $102k | Notice | SEC | |
| Aug 15, 2023 | Aug 15, 2023 | LYEL | Director | Form 144 notice | 4,485 | $10k | Notice | SEC | |
| Jul 17, 2023 | Jul 17, 2023 | LYEL | Officer, Director | Form 144 notice | 14,500 | $42k | Notice | SEC | |
| Jul 17, 2023 | Jul 17, 2023 | LYEL | Officer, Director | Form 144 notice | 3,300 | $10k | Notice | SEC | |
| Jul 17, 2023 | Jul 17, 2023 | LYEL | Officer, Director | Form 144 notice | 3,300 | $10k | Notice | SEC | |
| Jul 17, 2023 | Jul 17, 2023 | LYEL | Officer, Director | Form 144 notice | 3,300 | $10k | Notice | SEC | |
| Sep 23, 2022 | Sep 27, 2022 | LYEL | Director | Form 4 sale | 11,100 | $71k | 1.1% | Plan not stated | SEC |
| Jan 8, 2018 | Jan 9, 2018 | Juno Therapeutics, Inc. | Director | Form 4 sale | 12,724 | $613k | 1.7% | Plan not stated | SEC |
| Dec 21, 2017 | Dec 22, 2017 | Juno Therapeutics, Inc. | Director | Form 4 sale | 36,000 | $1.6M | 4.6% | Unusual | SEC |
| Sep 7, 2017 | Sep 8, 2017 | Juno Therapeutics, Inc. | Director | Form 4 sale | 12,000 | $512k | 1.5% | Plan not stated | SEC |
| Aug 7, 2017 | Aug 9, 2017 | Juno Therapeutics, Inc. | Director | Form 4 sale | 12,000 | $364k | 1.5% | Plan not stated | SEC |
| Jul 7, 2017 | Jul 7, 2017 | Juno Therapeutics, Inc. | Director | Form 4 sale | 24,000 | $705k | 2.9% | Plan not stated | SEC |
| Jun 7, 2017 | Jun 9, 2017 | Juno Therapeutics, Inc. | Director | Form 4 sale | 24,000 | $566k | 2.8% | Plan not stated | SEC |
| Jun 24, 2016 | Jun 24, 2016 | Juno Therapeutics, Inc. | Director | Form 4 sale | 12,000 | $489k | 1.4% | Plan not stated | SEC |
| May 18, 2016 | May 20, 2016 | Juno Therapeutics, Inc. | Director | Form 4 sale | 12,000 | $480k | 1.4% | Plan not stated | SEC |
| Apr 15, 2016 | Apr 19, 2016 | Juno Therapeutics, Inc. | Director | Form 4 sale | 12,000 | $515k | 1.4% | Plan not stated | SEC |
| Mar 22, 2016 | Mar 22, 2016 | Juno Therapeutics, Inc. | Director | Form 4 sale | 12,000 | $480k | 1.3% | Plan not stated | SEC |
| Mar 2, 2016 | Mar 2, 2016 | Juno Therapeutics, Inc. | Director | Form 4 sale | 24,000 | $970k | 2.6% | Plan not stated | SEC |
| Dec 15, 2015 | Dec 17, 2015 | Juno Therapeutics, Inc. | Director | Form 4 sale | 12,000 | $549k | 1.3% | Plan not stated | SEC |
| Nov 13, 2015 | Nov 16, 2015 | ILMN | Sr VP, Chief Medical Officer | Form 4 sale | 730 | $119k | 3.1% | Plan not stated | SEC |
| Nov 13, 2015 | Nov 13, 2015 | Juno Therapeutics, Inc. | Director | Form 4 sale | 12,000 | $594k | 1.3% | Plan not stated | SEC |
| Oct 15, 2015 | Oct 16, 2015 | Juno Therapeutics, Inc. | Director | Form 4 sale | 8,000 | $400k | 0.8% | Plan not stated | SEC |
| Oct 12, 2015 | Oct 13, 2015 | Juno Therapeutics, Inc. | Director | Form 4 sale | 16,000 | $800k | 1.7% | Plan not stated | SEC |
| Sep 28, 2015 | Sep 29, 2015 | ILMN | Sr VP, Chief Medical Officer | Form 4 sale | 423 | $73k | 1.7% | Plan not stated | SEC |
| Jul 15, 2015 | Jul 17, 2015 | Juno Therapeutics, Inc. | Director | Form 4 sale | 8,000 | $427k | 0.8% | Plan not stated | SEC |
| Jun 23, 2015 | Jun 25, 2015 | Juno Therapeutics, Inc. | Director | Form 4 sale | 8,000 | $418k | 0.8% | Plan not stated | SEC |
| Mar 10, 2015 | Mar 11, 2015 | ILMN | Sr VP, Chief Medical Officer | Form 4 sale | 1,186 | $227k | 4.5% | Plan not stated | SEC |